Upload
others
View
14
Download
0
Embed Size (px)
Citation preview
Classification of uterine corpus carcinomas,
carcinosarcomas and sarcomas
Focus on molecular approaches
Prof. Ben Davidson, MD PhD
Department of Pathology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
Issues
• Evolution
• Diagnosis
• Prognosis
• Therapy
Endometrial carcinoma
Matias-Guiu and Davidson, Virchows Arch 2014;464:315-331
Molecular pathways
Matias-Guiu and Davidson, Virchows Arch 2014;464:315-331
Prognosis
Uterine carcinosarcoma
Uterine sarcoma
• ESS cytogenetics: JAZF1-SUZ12 (JJAZ1)
JAZF1-PHF1
EPC1-PHF1
MEAF6-PHF1
ZC3H7B-BCOR
MBTD1-CXorf67
HG ESS: YWHAE-NUTM2A/B (FAM22A/B)
Summary
• The evolution of several uterine cancers is unclear
• Diagnosis is based on combination of morphology, IHC and
(in some situations) molecular findings
• There are distinct sub-groups with prognostic relevance
within established histological entities, most evidently in EEC
• The potential of targeted therapy is yet to be realized in
uterine cancer
Thank you for your attention